7-76303841-C-T
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PM1PM2PM5PP3_StrongPP5_Very_Strong
The NM_001540.5(HSPB1):c.404C>T(p.Ser135Phe) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S135C) has been classified as Likely pathogenic.
Frequency
Consequence
NM_001540.5 missense
Scores
Clinical Significance
Conservation
Publications
- Charcot-Marie-Tooth disease axonal type 2FInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen, Illumina, Labcorp Genetics (formerly Invitae)
- neuronopathy, distal hereditary motor, type 2BInheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
- distal hereditary motor neuropathy type 2Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 34
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Charcot-Marie-Tooth disease axonal type 2F Pathogenic:3
The variant is not observed in the gnomAD v2.1.1 dataset. Missense changes are a common disease-causing mechanism. In silico tool predictions suggest damaging effect of the variant on gene or gene product (REVEL: 0.94; 3Cnet: 0.99). Same nucleotide change resulting in same amino acid change has been previously reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000007478). Different missense changes at the same codon (p.Ser135Cys, p.Ser135Tyr) have been reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000533813, VCV000637060). Therefore, this variant is classified as pathogenic according to the recommendation of ACMG/AMP guideline. -
- -
For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Ser135 amino acid residue in HSPB1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 23963299). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Experimental studies have shown that this missense change affects HSPB1 function (PMID: 15122254, 17881652). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt HSPB1 protein function. ClinVar contains an entry for this variant (Variation ID: 7478). This missense change has been observed in individual(s) with autosomal dominant axonal Charcot-Marie-Tooth (CMT2) and distal hereditary motor neuronopathy type 2B (dHMN2B) (PMID: 15122254, 18832141). It has also been observed to segregate with disease in related individuals. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces serine, which is neutral and polar, with phenylalanine, which is neutral and non-polar, at codon 135 of the HSPB1 protein (p.Ser135Phe). -
not provided Pathogenic:1
This variant has not been reported in large, multi-ethnic general populations. This variant segregates with disease in multiple families. Assessment of experimental evidence suggests this variant results in abnormal protein function. (PMID: 15122254, 17881652, 20178975, 21785432) -
Neuronopathy, distal hereditary motor, type 2B Pathogenic:1
- -
Charcot-Marie-Tooth disease Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at